wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40318439-37FE78A4-C63A-4B7C-9002-FD276CDA95A2
Q40318439-37FE78A4-C63A-4B7C-9002-FD276CDA95A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40318439-37FE78A4-C63A-4B7C-9002-FD276CDA95A2
A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy.
P2860
Q40318439-37FE78A4-C63A-4B7C-9002-FD276CDA95A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40318439-37FE78A4-C63A-4B7C-9002-FD276CDA95A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
781ce375d108d09cf5dd6cae5973bdcb69427e5a
P2860
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.